The U.S. Food and Drug Administration has approved Lipfendra (enlicitide), a once-daily tablet intended to help lower low-density lipoprotein cholesterol,...
The U.S. Food and Drug Administration has approved Lipfendra (enlicitide), a once-daily tablet intended to help lower low-density lipoprotein cholesterol,...